Xconomy: Agenda: What's Hot in Boston Biotech


	AGENDA

	12:30 – 1:30	Registration
	1:30 – 1:40	Welcome Bob Buderi, Editor in Chief, Xconomy
	1:40 – 1:50	Opening Remarks Douglas Williams, EVP, Research and Development, Biogen Idec
	1:50 – 2:15	Profile 1: RNAi Therapeutics, Alnylam, and The Carrot Seed John Maraganore, CEO, Alnylam Pharmaceuticals
	2:15 – 2:45	Panel: New Models for Collaboration Richard Brudnick, VP, Business Development, Biogen Idec Robert Urban, Head, J&J Innovation Center, Boston Jason Rhodes, President and CFO, Epizyme Rob Armstrong, former VP, Global External Research and Development, Eli Lilly (moderator)
	2:45 – 3:15	Chat: Thoughts on the Past, Present, and Future of Biotech Michael Bonney, CEO, Cubist Pharmaceuticals Bob Buderi, Editor in Chief, Xconomy (moderator)
	3:15 – 3:45	Networking Break
	3:45 – 4:10	Profile 2: Gene Surgery With CRISPR/Cas9: The Editas Medicine Story Kevin Bitterman, Interim CEO, Editas Medicine; Partner, Polaris Partners Feng Zhang, Professor of Biomedical Engineering, MIT
	4:10 – 4:35	Profile 3: Gene Regulation and Contrarian Drug Development: The Syros Pharmaceuticals Story Nancy Simonian, CEO, Syros Pharmaceuticals
	4:35 – 5:05	Panel: New Alternatives for Financing Roger Stein, Chief Analytics Officer, State Street Global Exchange Katrine Bosley, Entrepreneur-in-residence, The Broad Institute (moderator)
	5:05 – 5:30	Profile 4: A Bottoms-Up View of the Microbiome: The Seres Health Story David Berry, CEO, Seres Health; Partner, Flagship Ventures
	5:30 – 6:30	Networking Reception

REGISTER NOW: xconomyforum68.eventbrite.com

Underwriters and Partners

Connect with Xconomy

Xconomy on Demand